PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Biochemistry and Molecular Biology, Louisiana State University Health Sciences Center School of Medicine, New Orleans, LA, USA.\', \'Department of Medical Sciences, University of Arkansas, Little Rock, AK, USA.\', \'Department of Biological Engineering, Louisiana State University, Baton Rouge, LA, USA.\', \'Department of Biochemistry and Molecular Biology, Louisiana State University Health Sciences Center School of Medicine, New Orleans, LA, USA; Stanley Scott Cancer Research Center, Louisiana State University Health Sciences Center, New Orleans, LA, USA. Electronic address: Salaha@lsuhsc.edu.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • S0006-2952(20)30532-310.1016/j.bcp.2020.114296
?:hasPublicationType
?:journal
  • Biochemical pharmacology
is ?:pmid of
?:pmid
?:pmid
  • 33191206
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 1.832
?:rankingScore_hIndex
  • 177
is ?:relation_isRelatedTo_publication of
?:title
  • Repurposing existing drugs for the treatment of COVID-19/SARS-CoV-2 infection: A review describing drug mechanisms of action.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all